TransMedics (TMDX) Invested Capital (2018 - 2026)

TransMedics' Invested Capital history runs 9 years deep, the most recent figure standing at $509.0 million for Q1 2026.

• In Q1 2026, Invested Capital rose 91.13% year-over-year to $509.0 million; the TTM figure through Mar 2026 stood at $509.0 million (up 91.13% YoY), while the FY2025 annual figure was $483.1 million, up 111.33% from the prior year.
• Invested Capital was $509.0 million for Q1 2026 at TransMedics, up from $483.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $509.0 million in Q1 2026 to a low of $50.9 million in Q2 2022.
• Historically, Invested Capital has averaged $224.2 million across 5 years, with a median of $189.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Invested Capital slumped 42.78% in 2022, then surged 221.52% in 2023.
• A 5-year view of Invested Capital shows it stood at $187.4 million in 2022, then declined by 26.78% to $137.2 million in 2023, then jumped by 66.62% to $228.6 million in 2024, then jumped by 111.33% to $483.1 million in 2025, then advanced by 5.36% to $509.0 million in 2026.
• The last three Invested Capital figures came in at $509.0 million (Q1 2026), $483.1 million (Q4 2025), and $360.2 million (Q3 2025), per Business Quant data.